Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-15 · accession 0001055726-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-16 | 2025-05-15 | INO | Sumner Michael John | Chief Medical Off | F - Tax | $1.95 | -680 | 14.9K | -4% | -$1,326 |
| D | 2025-05-16 | 2025-05-15 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | — | +2,385 | 15.6K | +18% | — |
| D | 2025-05-16 | 2025-05-15 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | $0.00 | -2,385 | 2,385 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | F | D | 680 | $1.95 | 14,934 | D | — | — | (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 2 | Common | Common Stock | 2025-05-15 | M | A | 2,385 | — | 15,614 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Derivative | Restricted Stock Unit | 2025-05-15 | M | D | 2,385 | $0.00 | 2,385 | D | — · — to — | 2,385 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |